Physician profile
Christopher M Nolte
NPI 1790768091
$7,095.13
in general payments reported to CMS, 2019-2025
14 companies · $4,418 in 2025
The $4,418 reported for 2025 was more than what 87% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $138 · 2021: $608 · 2022: $495 · 2023: $212 · 2024: $520 · 2025: $4,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,750 · Food and Beverage: $1,572 · Travel and Lodging: $528 · Consulting Fee: $200 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,750.00 |
| Food and Beverage | $1,571.54 |
| Travel and Lodging | $527.97 |
| Consulting Fee | $200.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $4,113.24 | 2019-2025 | Fisher & Paykel Healthcare |
| Philips North America LLC | $1,137.76 | 2019-2024 | (7999) Src Und |
| Jazz Pharmaceuticals INC. | $436.63 | 2019-2024 | Xywav |
| Avadel Cns Pharmaceuticals, LLC | $352.14 | 2023-2025 | Lumryz |
| Axsome Therapeutics, INC. | $317.01 | 2023-2025 | Sunosi |
| Nuvasive, INC. | $190.00 | 2021 | |
| Inspire Medical Systems, INC. | $180.84 | 2024-2025 | Inspire |
| Resmed Corp | $136.49 | 2019-2025 | |
| Harmony Biosciences LLC | $86.97 | 2022-2025 | |
| Breas Medical, INC. | $57.70 | 2024-2025 | Vivo 45 Ls |
| Ucb, INC. | $34.53 | 2019 | |
| Lilly USA, LLC | $18.43 | 2025 | Zepbound |
| 3b Medical, INC. | $18.25 | 2025 | Luna |
| Biogen, INC. | $15.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Nolte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.